Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”

Immunotherapy has dramatically changed the cancer treatment landscape during the past decade, but very limited efficacy has been reported against pancreatic cancer. Several factors unique to pancreatic cancer may explain the resistance: the well-recognized suppressive elements in the tumor microenvi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hester, Robert, Mazur, Pawel K., McAllister, Florencia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639640/
https://www.ncbi.nlm.nih.gov/pubmed/34193514
http://dx.doi.org/10.1158/1078-0432.CCR-18-0900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639640/
https://www.ncbi.nlm.nih.gov/pubmed/34193514
http://dx.doi.org/10.1158/1078-0432.CCR-18-0900

Ejemplares similares